NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

結核檢驗的全球市場:各試驗類型,各終端用戶的市場調查,預測(∼2025年),COVID-19的累積性的影響

Tuberculosis Testing Market Research Report by Test Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1002730
出版日期 內容資訊 英文 196 Pages
商品交期: 最快1-2個工作天內
價格
結核檢驗的全球市場:各試驗類型,各終端用戶的市場調查,預測(∼2025年),COVID-19的累積性的影響 Tuberculosis Testing Market Research Report by Test Type, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 196 Pages
簡介

全球結核檢驗的市場規模預測將從2020年的20億9,787萬美元,到2025年末達到28億5,443萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

 

這份報告提供結核檢驗的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,試驗類型·終端用戶·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查對象涵蓋年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 試驗類型預測
  • 終端用戶預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章各試驗類型

  • 培養為基礎的試驗
  • 藥物敏感性試驗
  • 核酸試驗
  • X光攝影
  • 污點顯微鏡

第7章 各終端用戶

  • 醫院
  • 研究所

第8章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東·非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Abbott Laboratories
  • Akonni Biosystems, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Cepheid
  • Epistem Holdings Plc
  • F. Hoffmann-La Roche AG
  • Siemens Healthineer Inc.
  • Thermo Fischer Scientific Inc.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-03252A5F927B

The Global Tuberculosis Testing Market size was estimated at USD 2,097.87 Million in 2020 and expected to reach USD 2,241.63 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.19% to reach USD 3,182.21 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Tuberculosis Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Test Type, the Tuberculosis Testing Market was studied across Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing, Radiography, and Smear Microscopy.

Based on End User, the Tuberculosis Testing Market was studied across Hospital and Laboratories.

Based on Geography, the Tuberculosis Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tuberculosis Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tuberculosis Testing Market, including Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMerieux SA, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Siemens Healthineer Inc., and Thermo Fischer Scientific Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Tuberculosis Testing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tuberculosis Testing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tuberculosis Testing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Tuberculosis Testing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Tuberculosis Testing Market?
  • 6. What is the market share of the leading vendors in the Global Tuberculosis Testing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Tuberculosis Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Test Type Outlook
  • 3.4. End User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the prevalence of drug-resistant tuberculosis infection
      • 5.1.1.2. Improvement in bacteriological confirmation
      • 5.1.1.3. Increase in awareness enabling proper management of the disease
    • 5.1.2. Restraints
      • 5.1.2.1. Development of advanced and hybrid technique of multiple disorder detection
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for improved and technologically advanced tuberculosis testing procedures
      • 5.1.3.2. Growing tuberculosis awareness and control programs
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of supply of TST antigens in various regions
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Tuberculosis Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Culture Based Tests
  • 6.3. Drug Susceptibility Testing
  • 6.4. Nucleic Acid Testing
  • 6.5. Radiography
  • 6.6. Smear Microscopy

7. Tuberculosis Testing Market, by End User

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Laboratories

8. Americas Tuberculosis Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Tuberculosis Testing Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Tuberculosis Testing Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Akonni Biosystems, Inc.
  • 12.3. Alere, Inc.
  • 12.4. Becton, Dickinson and Company
  • 12.5. bioMerieux SA
  • 12.6. Cepheid
  • 12.7. Epistem Holdings Plc
  • 12.8. F. Hoffmann-La Roche AG
  • 12.9. Siemens Healthineer Inc.
  • 12.10. Thermo Fischer Scientific Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL TUBERCULOSIS TESTING MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL TUBERCULOSIS TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2026
  • FIGURE 10. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TESTS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RADIOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RADIOGRAPHY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SMEAR MICROSCOPY, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SMEAR MICROSCOPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2026
  • FIGURE 23. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LABORATORIES, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 28. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 30. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. CALIFORNIA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. FLORIDA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. ILLINOIS TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. NEW YORK TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. OHIO TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. PENNSYLVANIA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. TEXAS TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 43. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 45. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. INDIA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. INDONESIA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. JAPAN TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. MALAYSIA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PHILIPPINES TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. SOUTH KOREA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. THAILAND TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 56. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. NETHERLANDS TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. QATAR TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. SAUDI ARABIA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. SOUTH AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. UNITED ARAB EMIRATES TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GLOBAL TUBERCULOSIS TESTING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 68. GLOBAL TUBERCULOSIS TESTING MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 69. GLOBAL TUBERCULOSIS TESTING MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TUBERCULOSIS TESTING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL TUBERCULOSIS TESTING MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RADIOGRAPHY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SMEAR MICROSCOPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CALIFORNIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CALIFORNIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. FLORIDA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. FLORIDA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ILLINOIS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ILLINOIS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. NEW YORK TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. NEW YORK TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. OHIO TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. OHIO TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. PENNSYLVANIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. PENNSYLVANIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. TEXAS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. TEXAS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. INDIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDONESIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDONESIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. JAPAN TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. JAPAN TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. MALAYSIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MALAYSIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PHILIPPINES TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PHILIPPINES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. SOUTH KOREA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. SOUTH KOREA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. THAILAND TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. THAILAND TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. NETHERLANDS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. NETHERLANDS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. QATAR TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. QATAR TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. SAUDI ARABIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SAUDI ARABIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. UNITED ARAB EMIRATES TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED ARAB EMIRATES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. GLOBAL TUBERCULOSIS TESTING MARKET: SCORES
  • TABLE 85. GLOBAL TUBERCULOSIS TESTING MARKET: BUSINESS STRATEGY
  • TABLE 86. GLOBAL TUBERCULOSIS TESTING MARKET: PRODUCT SATISFACTION
  • TABLE 87. GLOBAL TUBERCULOSIS TESTING MARKET: RANKING
  • TABLE 88. GLOBAL TUBERCULOSIS TESTING MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 89. GLOBAL TUBERCULOSIS TESTING MARKET: SHARE, BY COMPANY, 2020
  • TABLE 90. GLOBAL TUBERCULOSIS TESTING MARKET: MERGER & ACQUISITION
  • TABLE 91. GLOBAL TUBERCULOSIS TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 92. GLOBAL TUBERCULOSIS TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 93. GLOBAL TUBERCULOSIS TESTING MARKET: INVESTMENT & FUNDING
  • TABLE 94. GLOBAL TUBERCULOSIS TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 95. GLOBAL TUBERCULOSIS TESTING MARKET: LICENSE & PRICING
  • TABLE 96. GLOBAL TUBERCULOSIS TESTING MARKET: CONTACT DETAILS